Teva Pharm Q2 profit, revenue up on generic launches
July 31, 2014 at 07:25 AM EDT
TEL AVIV, July 31 (Reuters) - Teva Pharmaceutical Industries reported on Thursday higher quarterly earnings that beat analysts' estimates by one cent due in part to the launch of several generic products in the United States.
